Download PDF
Thromb Haemost 1984; 51(02): 294
DOI: 10.1055/s-0038-1661082
Letter to the Editor
Schattauer GmbH Stuttgart

Amidolytic Prekallikrein (PK) Assay: Unsuitability of Cephotest® as an Activator

Bernhard Lämmle
Coagulation and Fibrinolysis Laboratory, Kantonsspital, 4031 Basel, Switzerland
,
Andreas Lohri
Coagulation and Fibrinolysis Laboratory, Kantonsspital, 4031 Basel, Switzerland
,
Tri H Tran
Coagulation and Fibrinolysis Laboratory, Kantonsspital, 4031 Basel, Switzerland
,
Czeslav Czendlik
Coagulation and Fibrinolysis Laboratory, Kantonsspital, 4031 Basel, Switzerland
› Author Affiliations
Further Information

Publication History

Received 24 January 1984

Accepted 03 February 1984

Publication Date:
19 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Lämmle B, Tran TH. The amidolytic prekallikrein (PK) determination: enhanced PK activation after deep-freezing of patients’ plasma. Thromb Haemostas 1983; 49: 249
    PubMedGoogle Scholar
  • 2 Friberger P, Eriksson E, Gustavsson S, Claeson G. Determination of prekallikrein in plasma by means of a chromogenic tripeptide substrate for plasma kallikrein. Adv Exp Med Biol 1979; 120 A 67-82
    PubMedGoogle Scholar
  • 3 Kluft C. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. J Lab Clin Med 1978; 91: 83-95
    PubMedGoogle Scholar
  • 4 Lämmle B, Tran TH, Ritz R, Duckert F. Plasma prekallikrein, factor XII antithrombin III, C1-Inhibitor and α2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Clin Pathol. (in press)
    PubMedGoogle Scholar
  • 5 Gallimore MJ, Friberger P. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein “like” activity in human plasma. Thromb Res 1982; 25: 293-298
    CrossrefPubMedGoogle Scholar